316 related articles for article (PubMed ID: 27121319)
1. TET1 inhibits gastric cancer growth and metastasis by PTEN demethylation and re-expression.
Pei YF; Tao R; Li JF; Su LP; Yu BQ; Wu XY; Yan M; Gu QL; Zhu ZG; Liu BY
Oncotarget; 2016 May; 7(21):31322-35. PubMed ID: 27121319
[TBL] [Abstract][Full Text] [Related]
2. Decrease of 5hmC in gastric cancers is associated with TET1 silencing due to with DNA methylation and bivalent histone marks at TET1 CpG island 3'-shore.
Park JL; Kim HJ; Seo EH; Kwon OH; Lim B; Kim M; Kim SY; Song KS; Kang GH; Kim HJ; Choi BY; Kim YS
Oncotarget; 2015 Nov; 6(35):37647-62. PubMed ID: 26462176
[TBL] [Abstract][Full Text] [Related]
3. CagA increases DNA methylation and decreases PTEN expression in human gastric cancer.
Zhang B; Zhang X; Jin M; Hu L; Zang M; Qiu W; Wang S; Liu B; Liu S; Guo D
Mol Med Rep; 2019 Jan; 19(1):309-319. PubMed ID: 30431097
[TBL] [Abstract][Full Text] [Related]
4. TET1-mediated DNA hydroxymethylation activates inhibitors of the Wnt/β-catenin signaling pathway to suppress EMT in pancreatic tumor cells.
Wu J; Li H; Shi M; Zhu Y; Ma Y; Zhong Y; Xiong C; Chen H; Peng C
J Exp Clin Cancer Res; 2019 Aug; 38(1):348. PubMed ID: 31399111
[TBL] [Abstract][Full Text] [Related]
5. TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway.
Neri F; Dettori D; Incarnato D; Krepelova A; Rapelli S; Maldotti M; Parlato C; Paliogiannis P; Oliviero S
Oncogene; 2015 Aug; 34(32):4168-76. PubMed ID: 25362856
[TBL] [Abstract][Full Text] [Related]
6. TET1 exerts its tumor suppressor function by interacting with p53-EZH2 pathway in gastric cancer.
Fu HL; Ma Y; Lu LG; Hou P; Li BJ; Jin WL; Cui DX
J Biomed Nanotechnol; 2014 Jul; 10(7):1217-30. PubMed ID: 24804542
[TBL] [Abstract][Full Text] [Related]
7. Loss of TET1 facilitates DLD1 colon cancer cell migration via H3K27me3-mediated down-regulation of E-cadherin.
Zhou Z; Zhang HS; Liu Y; Zhang ZG; Du GY; Li H; Yu XY; Huang YH
J Cell Physiol; 2018 Feb; 233(2):1359-1369. PubMed ID: 28513825
[TBL] [Abstract][Full Text] [Related]
8. Loss of ten-eleven translocation 1 (TET1) expression as a diagnostic and prognostic biomarker of endometrial carcinoma.
Liu NT; Perng CL; Chou YC; Ko PS; Lin YJ; Lin YC; Chang CC; Wang YC; Shang HS; Chao TK
PLoS One; 2021; 16(11):e0259330. PubMed ID: 34731191
[TBL] [Abstract][Full Text] [Related]
9. Robust quantitative assessments of cytosine modifications and changes in the expressions of related enzymes in gastric cancer.
Du C; Kurabe N; Matsushima Y; Suzuki M; Kahyo T; Ohnishi I; Tanioka F; Tajima S; Goto M; Yamada H; Tao H; Shinmura K; Konno H; Sugimura H
Gastric Cancer; 2015 Jul; 18(3):516-25. PubMed ID: 25098926
[TBL] [Abstract][Full Text] [Related]
10. PTEN inhibits the invasion and metastasis of gastric cancer via downregulation of FAK expression.
Zhang LL; Liu J; Lei S; Zhang J; Zhou W; Yu HG
Cell Signal; 2014 May; 26(5):1011-20. PubMed ID: 24486402
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol inhibits the tumor migration and invasion by upregulating TET1 and reducing TIMP2/3 methylation in prostate carcinoma cells.
Wang K; Chen Z; Shi J; Feng Y; Yu M; Sun Y; Zhuang Q; Liang B; Luo G; Xu X; Fan M
Prostate; 2020 Sep; 80(12):977-985. PubMed ID: 32542727
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA‑4284 promotes gastric cancer tumorigenicity by targeting ten-eleven translocation 1.
Li Y; Shen Z; Jiang H; Lai Z; Wang Z; Jiang K; Ye Y; Wang S
Mol Med Rep; 2018 May; 17(5):6569-6575. PubMed ID: 29512746
[TBL] [Abstract][Full Text] [Related]
13. TET1 suppresses colon cancer proliferation by impairing β-catenin signal pathway.
Guo H; Zhu H; Zhang J; Wan B; Shen Z
J Cell Biochem; 2019 Aug; 120(8):12559-12565. PubMed ID: 30825236
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-induced TET1 facilitates trophoblast cell migration and invasion through HIF1α signaling pathway.
Zhu J; Wang K; Li T; Chen J; Xie D; Chang X; Yao J; Wu J; Zhou Q; Jia Y; Duan T
Sci Rep; 2017 Aug; 7(1):8077. PubMed ID: 28808304
[TBL] [Abstract][Full Text] [Related]
15. Association of TET1 expression with colorectal cancer progression.
Tian Y; Pan F; Sun X; Gan M; Lin A; Zhang D; Zhu Y; Lai M
Scand J Gastroenterol; 2017 Mar; 52(3):312-320. PubMed ID: 27846738
[TBL] [Abstract][Full Text] [Related]
16. Ten-eleven translocation 1 (TET1) gene is a potential target of miR-21-5p in human colorectal cancer.
Cheng YW; Chou CJ; Yang PM
Surg Oncol; 2018 Mar; 27(1):76-81. PubMed ID: 29549908
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of ten-eleven translocation genes in endometrial cancers.
Ciesielski P; Jóźwiak P; Wójcik-Krowiranda K; Forma E; Cwonda Ł; Szczepaniec S; Bieńkiewicz A; Bryś M; Krześlak A
Tumour Biol; 2017 Mar; 39(3):1010428317695017. PubMed ID: 28349832
[TBL] [Abstract][Full Text] [Related]
18. GADD45a physically and functionally interacts with TET1.
Kienhöfer S; Musheev MU; Stapf U; Helm M; Schomacher L; Niehrs C; Schäfer A
Differentiation; 2015; 90(1-3):59-68. PubMed ID: 26546041
[TBL] [Abstract][Full Text] [Related]
19. Effects of ten-eleven translocation 1 (Tet1) on DNA methylation and gene expression in chicken primordial germ cells.
Yu M; Li D; Cao W; Chen X; Du W
Reprod Fertil Dev; 2019 Mar; 31(3):509-520. PubMed ID: 30282572
[TBL] [Abstract][Full Text] [Related]
20. Loss of 5-hydroxymethylcytosine is accompanied with malignant cellular transformation.
Kudo Y; Tateishi K; Yamamoto K; Yamamoto S; Asaoka Y; Ijichi H; Nagae G; Yoshida H; Aburatani H; Koike K
Cancer Sci; 2012 Apr; 103(4):670-6. PubMed ID: 22320381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
